UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 4, 2021
Accession Number: 0001493152-21-011691
Submission Type: POS AM
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-235301